基本信息 产品详情 公司简介 推荐产品
网站主页 1628607-64-6 INCB054329
  • aladdin 阿拉丁 I408086 INCB054329 1628607-64-6 10mM in DMSO

aladdin 阿拉丁 I408086 INCB054329 1628607-64-6 10mM in DMSO

INCB054329
1628607-64-6
2060.90 1ml 起订
上海 更新日期:2024-08-16

上海阿拉丁生化科技股份有限公司

VIP1年
联系人:阿拉丁客服
手机:+86-18521732826 拨打
邮箱:market@aladdin-e.com

产品详情:

中文名称:
INCB054329
英文名称:
INCB054329
CAS号:
1628607-64-6
品牌:
阿拉丁
产地:
上海
保存条件:
-80℃储存
纯度规格:
10mM in DMSO
产品类别:
药靶配体 药靶配体
分子式:
C19H16N4O3
分子量:
348.36
运输条件:
超低温冰袋运输
产品规格:
1ml
货号:
I408086
是否进口:

中文名:INCB054329

英文名:INCB054329

英文别名:INCB-054329, INCB-54329;Imidazo[1,​5,​4-​de]​[1,​4]​benzoxazin-​2(1H)​-​one, 7-​(3,​5-​dimethyl-​4-​isoxazolyl)​-​4,​5-​dihydro-​4-​(2-​pyridinyl)​-​, (4S)​-

纯度:10mM in DMSO

货号:I408086

包装:1ml

Cas号:1628607-64-6

存储温度:-80℃储存

产品介绍:

Information

INCB054329 INCB054329 (INCB-054329, INCB-54329) is a structurally distinct bromodomain and extraterminal domain (BET) inhibitor with IC50 values of 44 nM, 5 nM, 9 nM, 1 nM, 28 nM, 3 nM, 119 nM and 63 nM for BRD2-BD1, BRD2-BD2, BRD3-BD1, BRD3-BD2, BRD4-B
In vitro

INCB054329 shows no significant inhibitory activity against 16 non-BET bromodomains at 3 μM. In a panel of 32 hematologic cancer cell lines derived from acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma, the median 50% growth inhibition (GI50) value of INCB054329 is 152 nM (range, 26-5000 nM). In contrast to tumor cell lines, the GI50 value against T cells isolated from non-diseased donors stimulated ex vivo with IL-2 is 2.435 μM. Growth inhibition correlates with a concentration-dependent accumulation of cells in the G1 phase of the cell cycle. INCB054828 is also a selective kinase inhibitor of the FGFR 1, 2, and 3. In myeloma cell lines, treatment with INCB054329 inhibits expression of c-MYC and induced HEXIM1. In both AML and lymphoma cell lines, INCB054329 induces apoptosis consistent with increased expression of pro-apoptotic regulators. INCB054329 reduces expression of Homologous recombination (HR) components and co-operatively reduces cell growth and increases DNA damage and apoptosis induced by PARPi and cisplatin.

In vivo

INCB054329 exhibits high clearance in mice resulting in a short half-life. At exposures that effectively suppressed c-MYC, INCB054329 is found to be efficacious and well tolerated in both the KMS-12-BM and MM1.S xenograft models. In vivo, oral administration of INCB054329 inhibits tumor growth in several models of hematologic cancers.
Cell Data

cell lines:

Concentrations:--

Incubation Time:72 h

Powder Purity:≥98%

查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/I408086.html


INCB-054329, INCB-54329;Imidazo[1,?5,?4-?de]?[1,?4]?benzoxazin-?2(1H)?-?one, 7-?(3,?5-?dimethyl-?4-?isoxazolyl)?-?4,?5-?dihydro-?4-?(2-?pyridinyl)?-?, (4S)?-

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (16年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

内容声明
拨打电话 立即询价